WHO Published New Contraceptive Guidelines
The international agency issued updated recommendations to expand access to modern birth control methods worldwide.
Updated on Sept. 23, 2026 in Women’s Health
Live Poll
Do you believe expanded access to a wider range of contraceptive options benefits your community?
The World Health Organisation has released comprehensive guidelines to help countries increase access to evidence-supported contraceptive options. The agency identified a significant global gap, with an estimated 164 million women currently unable to access their desired family planning methods.
Why it matters
These guidelines aim to address the needs of women seeking to delay or avoid pregnancy by providing clear, science-backed standards for providers. The initiative also shifts focus toward future male contraceptive development to broaden the scope of reproductive responsibility.
The guidelines endorse contraceptive implants for up to five years and oral pills for continuous use up to one year. Additionally, mifepristone is now recommended as an emergency contraceptive at doses between 10mg and 50mg for use within five days.
The players
World Health Organisation
The United Nations agency responsible for international public health that coordinates global responses to medical crises and sets health standards.
The details
The agency also released its first Target Product Profile for male contraceptives, noting that while 30 percent of couples currently rely on male-led methods, over 85 percent of women would trust their partners with such responsibilities. The organization cautioned that no new methods should be introduced without sufficient evidence and explicitly advised against the inclusion of quinestrol-containing pills in national programs.
Timeline
September 23, 2026: The World Health Organisation published the new contraceptive guidelines.
Next 5 to 10 years: New reversible male contraceptives are expected to become available for public use.
The Big Picture
The release of the WHO Guidelines on Expanding Contraceptive Options represents a shift in standardizing care for reproductive health. This effort follows a pattern set by previous international public health mandates that seek to harmonize medical practices across diverse national systems.
These guidelines simplify daily health routines by confirming the efficacy of extended-duration implants and year-long oral pill regimens. Patients may also see increased access to emergency options like mifepristone as healthcare providers adopt these newly established international standards.
The takeaway
These guidelines signal a major move toward diversifying available birth control options for both men and women. Improving access to reliable methods can empower individuals to make informed decisions about their reproductive health and family planning goals.
Further reading
Learn more about the latest standards in Women’s Health.
Live Poll
Do you believe expanded access to a wider range of contraceptive options benefits your community?
